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ABSTRACT
Objectives Patient and public involvement (PPI) in 
research priority- setting remains limited, especially for 
non- HIV STI. We identify and compare the top 10 patient 
and public STI research priorities with those of clinicians 
and STI stakeholders.
Methods This two- stage study was conducted in 
May–August 2019. First, STI research priorities were 
canvassed through qualitative questionnaires issued 
to all patients attending a large sexual health clinic, all 
clinicians in region- wide mailing lists, all stakeholders 
identified through existing networks and the Charity 
Commission database, and to the Liverpool public. Raw 
responses were organised by theme into a shortlist of 
25. In stage 2, these were ranked through priority- setting 
activities by telephone with patients and the public (n=8) 
and some clinicians (n=3), and in two workshops with 
clinicians (n=26) and stakeholders (n=5), respectively. 
The top 10 priorities were compared.
Results Of 373 surveys submitted, 106 were analysed 
(83 patient and public; 23 clinician and stakeholder). 
Exclusions included lack of completion and responses 
out of scope. Among patient and public respondents, 
55% (n=46) were aged 18–24 years, 51% (n=42) 
identified as heterosexual women and 23% (n=19) as 
men who have sex with men. Clinicians included all 
cadres; stakeholders were academics, commissioners and 
third sector representatives. In stage 2, 4 of 10 themes 
(STI education, targeted services for high- risk groups, 
antibiotic resistance and counselling for those with STI) 
were prioritised by all. Remote STI services and rapid 
diagnostics also ranked highly but the rationale differed 
between groups.
Conclusion This is the first non- HIV STI research 
priority- setting exercise to be reported in the UK. It 
identifies overlaps and differences between public 
and provider concerns, highlights gaps in the public 
understanding of STI research, and shows how PPI can 
promote research responsive to the concerns of both 
those who use and deliver services.
INTRODUCTION
Non- HIV STI pose a significant risk to public 
health in England. In addition to the specific threat 
of multidrug- resistant gonorrhoea, overall rates 
of gonorrhoea, syphilis and chlamydia are rising.1 
STIs are therefore an important research priority. 
Involving patients, the public and other key stake-
holders or ‘end- users’ in research priority- setting 
(RPS) is an important means of optimising research 
impact by ensuring that studies address the issues 
which end- users feel are most pressing.2–4
Despite this and the increasing use of patient and 
public involvement (PPI) in HIV RPS,5 evidence of 
PPI in non- HIV STI RPS is limited. Instead, layper-
sons are more commonly advisors or collaborators 
in research that is already funded.6 Transparent 
reporting of PPI methodology within this is rarer 
still. Previous studies have used a modified Delphi 
process for bacterial STI research priorities in 
Canada7 and explored multidrug- resistant gonor-
rhoea priorities using focus group discussions with 
an international expert panel on STI.8 A further 
opinion piece identified global STI priorities but 
did not describe PPI.9
We report the first exercise of its kind in the UK 
which aimed to identify the top 10 STI research 
priorities through rigorous, iterative RPS involving 
patients, the public, clinicians and STI stakeholders. 
Our priority- setting exercise was conducted in the 
North West (NW) of England as defined by the 
National Institute for Health Research NW Coast 
Clinical Research Network region (Cheshire, 
Merseyside, Lancashire and Cumbria), which 
excludes Greater Manchester. The NW has the 
highest incidence of new STI in the UK outside 
London.10
METHODS
A two- stage study was conducted using a vali-
dated approach.3 11 Priorities were first captured 
via a qualitative questionnaire and ranked to form 
a shortlist in stage 1, before interactive priority- 
setting in stage 2 through workshops and interviews 
to create a final top 10 among specific groups.
Stage 1
In May 2019 four categories of individuals were 
invited to participate in the questionnaire through 
(1) waiting room posters and paper questionnaires 
offered to all patients attending a large integrated 
sexual health clinic; (2) emails to all clinician 
members (nurses, healthcare assistants, health 
advisors and doctors) of the Cheshire and Mersey 
branch of the BASHH and to all lead clinicians in 
sexual health clinics in the study area; (3) emails 
to NW stakeholders (eg, support centres and advo-
cacy groups) identified through existing collabo-
rator networks and the 2019 Charity Commission 
database12; and finally (4) an open call to boost 
recruitment from the Liverpool public through 
stakeholder newsletters, social media and flyers 
 on S
eptem














2 Browne HL, et al. Sex Transm Infect 2021;0:1–6. doi:10.1136/sextrans-2021-055054
Original research
at a local university. Minority groups such as black, Asian and 
minority ethnicities (BAME), lesbian, gay, bisexual and trans-
gender (LGBT), and refugee communities were targeted through 
stakeholder networks. Persons aged below 18 years and not 
resident or working in the NW were not eligible. Invitations 
included a Quick Response (QR) code to the questionnaire, 
participation information and a request to forward the informa-
tion on to staff and/or service users.
Participation was voluntary and the questionnaire, available 
in identical paper and online formats, followed the James Lind 
Alliance (JLA) model.11 First, respondents were asked what they 
understood by the term STI and then to list research priorities 
from their own perspective under predetermined overarching 
categories: STI prevention, STI causes, STI diagnosis, STI treat-
ment and care, STI service delivery, and other. Identifiable infor-
mation was not collected. Participants could volunteer email 
or phone details as consent to be contacted regarding stage 2. 
This information was stored separately from survey responses to 
maintain anonymity.
An initial pilot questionnaire among patients and the public 
highlighted a potential lack of common understanding of the 
concept of ‘research’ and how subgroups may interpret the same 
item differently. Questions were refined to improve focus on 
research rather than personal or service queries. Public under-
standing of research was further explored during interviews.
Questionnaires which did not include at least one STI research 
priority or only included priorities out of scope (eg, questions 
that had already been clearly addressed) were excluded. Analysis 
was conducted by HLB and reviewed by senior authors to ensure 
integrity.
Patient and public (P&P) responses were analysed together, as 
were clinician and stakeholder (C&S) data. P&P priorities were 
further stratified by gender, sexual orientation and age to allow 
comparative analysis.
Where respondents identified multiple priorities, each item 
was considered as a ‘raw submission’. Raw submissions were 
analysed using a mix of thematic analysis13 and the JLA Data 
Management Framework11 to induce recurring STI research 
priority themes. Data saturation was achieved when no new 
themes emerged. The number of raw submissions for each STI 
research priority theme was calculated and used to rank and 
create a shortlist of 25 research priorities.
Stage 2
Shortlisted priorities were discussed during semistructured tele-
phone interviews with P&P (n=8) and some clinicians (n=3), 
and two separate workshops for clinicians (n=26) and stake-
holders (n=5), respectively. Participants were recruited directly 
from stage 1 via email or telephone call, and through promo-
tional material, existing stakeholder networks and convenience 
sampling at a departmental journal club.
Each participant was sent the shortlist prior to the interview/
workshop. Both interviews and workshops were facilitated by 
HLB to ensure consistency and followed a similar structure (to 
JLA methodology using an interactive, modified nominal group 
technique11) to group the shortlist into high (2 points), medium 
(1 point) or low (0 point) priority categories. This was done 
independently during interviews and within small groups in the 
workshops. Priorities were allocated a score depending on their 
grouping as described above, and aggregate scores from all inter-
views and workshops were calculated for each priority. Overall 
scores were used to identify and rank the final top 10 STI 
research priorities for P&P and C&S, respectively. Interviews 
and workshops were recorded, anonymised and transcribed with 
consent. Thematic analysis identified and explored similarities 
and differences between participant groups and their respective 
justifications for prioritisation. P&P interviews also explored 
participant understanding of the concept of research and its 
perceived relevance and importance to them as individuals.
All participants gave informed consent before taking part.
RESULTS
In total, 373 questionnaires were returned (348 P&P; 25 C&S), 
of which 226 (60.6%) answered one or more questions. Of these, 
52 were inappropriate, for example, “Use a condom!” (D28); 11 
were out of scope, for example, “Where did STIs come from?” 
(D25); and 57 were already answered, for example, “Can you 
catch genital warts if the person who has them isn’t having a 
flare up?” (D42) and therefore excluded. The remaining 106 (83 
P&P; 23 C&S) were analysed (figure 1).
Among P&P, 55% (n=46) were aged 18–24 years, 24% 
(n=20) aged 25–34 years and 19% (n=16) aged 35+ years. 
Half (51%, n=42) identified as being heterosexual women, 
23% (n=19) as men who have sex with men (MSM) and 18% 
(n=15) as heterosexual men. Only one respondent identified as 
a bisexual woman or a lesbian, respectively.
Among C&S, 57% (n=13) were doctors, 17% (n=4) were 
representatives from third sector organisations including those 
who support commercial sex workers and those living with 
HIV, 9% (n=2) were nurses, 9% (n=2) were commissioners and 
4% (n=1) were academics. One respondent did not state their 
profession. Of C&S, 74% (n=17) were female, 78% (n=18) 
were aged 35+ and the distribution of sexual orientation was 
similar to P&P.
Stage 1
The 118 raw submissions from P&P were coded into 32 STI 
research themes and 184 from C&S were coded into 45 themes. 
There were 28 themes overall, and 13 of the top 25 shortlists 
were the same or similar for each group (figure 2).
Among the P&P responses, all genders prioritised research into 
STI prevention measures other than condoms, rapid diagnostics, 
prevention of human papilloma virus (HPV), and more focus on 
STI health promotion and sex and relationship education (SRE). 
Men appeared more likely to call for increased research into STI 
prevention (57%, n=4 of male priorities compared with 21%, 
n=5 of female priorities). Women suggested a more diverse 
array of research priorities, including mental health, tackling 
STI stigma, STI treatments and drug resistance, and the role of 
digital service provision.
For MSM, the main priority was STI prevention, with health 
promotion and gonorrhoea and syphilis antibiotic resistance 
proving popular. All ages suggested HIV research priorities 
including pre- exposure prophylaxis, treatment of HPV, STI 
prevention measures other than condoms and SRE as important 
research priorities. Rapid diagnostics was the most prevalent in 
respondents aged 18–24 (72%, n=8 raw submissions).
Stage 2
Among the P&P interviewees, 63% (n=5) were female, 63% 
(n=5) were aged 18–24 years, 75% (n=6) identified as hetero-
sexual and all were white British. Clinicians were diverse, 
including nurse practitioners (n=8), consultants (n=5), junior 
doctors (n=2), nurses (n=6), healthcare assistants (n=5), 
student nurses (n=2) and health advisor (n=1). Stakeholders 
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included those in leadership roles at local third sector organi-
sations, Public Health England and commissioners.
C&S results were combined to create a joint top 10. STI 
education, targeted STI services for high- risk groups, STI 
resistance, and counselling and emotional support feature in 
the top 10 for both P&P and C&S (figure 3).
STI health promotion and SRE are separate for P&P but combined 
under ‘STI education’ for C&S. C&S considered STI education in 
the broader sense with a focus on STI health promotion and fewer 
survey responses specific to SRE. For P&P, SRE in schools was a 
separate focal point from the outset and during the priority- setting; 
the two priorities were continuously examined as separate entities.
Figure 1 Flow of data outcomes.
Figure 2 Details and distributions of all STI research priority themes identified from the surveys. Priorities marked with an asterisk (*) featured in 
both top 25 shortlists. HPV, human papilloma virus; HSV herpes simplex virus; MSM, men who have sex with men; PrEP, pre- exposure prophylaxis; 
SRE, sex and relationship education.
 on S
eptem














4 Browne HL, et al. Sex Transm Infect 2021;0:1–6. doi:10.1136/sextrans-2021-055054
Original research
Regardless of background or expertise, a focus on “prevention 
is always better than treating” (PI5) was evident, with STI health 
promotion and SRE highly prioritised. Most P&P interviewees 
argued that SRE should be “absolutely compulsory” (PI1), age- 
appropriate, inclusive and “more representative of a healthy 
sexuality rather than… the physical aspects” (PI2). Clinicians felt 
that health promotion research would have a profound impact 
on “risk reduction, [decreasing] harm and patients having the 
best sexual health” (C2).
Targeted STI services for high- risk groups was another 
priority. Similar examples were given by all participant types, 
such as those with learning and physical disabilities, the elderly, 
young people, commercial sex workers, “BAME, refugee and 
asylum- seeking communities and LGBT people especially the 
trans community” (SH1).
STI antibiotic resistance was the third most important P&P 
priority and over half (57.1%) of clinicians voted it as one of 
their most urgent. P&P clearly felt that “Mental health is a 
priority” (C1). Most interviewees in this group ranked coun-
selling and emotional support as a high or medium priority and 
C&S also supported this with regard to late HIV diagnoses.
Although they did not appear in both top 10s, the importance 
of other key themes was repeatedly highlighted in both data sets. 
Rapid diagnostics with respect to increasing efficiency in clinic, 
point- of- care tests for chlamydia and gonorrhoea, and under-
standing risk- taking and sexual behaviours such as chemsex and 
dating apps to “stem the flow” (SH4) also featured.
Conflicting perspectives emerged in relation to remote STI 
services and a digital approach to service delivery. Most C&S 
prioritised research into online services and home testing kits, 
whereas P&P voiced concerns over their accuracy and safety.
Given the abundance of existing HIV RPS and participatory 
research with those living with HIV, our intention was to create 
a space for discussing non- HIV STI. Despite the explicit focus on 
non- HIV STI in study materials, HIV priorities proved popular 
and were linked with counselling, emotional support and mental 
health.
Finally, of note, there was clear enthusiasm for PPI in RPS 
across groups, with several respondents commenting on how 




To our knowledge, this is the first intentionally non- HIV STI 
RPS exercise in the UK. It therefore extends the literature on 
public engagement in non- HIV STI research.
STI health promotion and education, targeted services for 
high- risk groups, STI treatment resistance, and counselling and 
emotional support were among the top 10 priorities across all 
groups. The high priority given to STI antibiotic resistance is 
unsurprising given publicity surrounding increasing prevalence, 
especially for gonorrhoea.10 However, this was outranked by 
preventative activities including health promotion and educa-
tion. Indeed participants evidenced nuanced understanding of 
prevention activities, calling specifically for research exploring 
risk- taking and sexual behaviours and to develop targeted 
services and interventions for high- risk groups. Mental health 
was another important priority, with counselling and emotional 
support ranking highly and stimulating rich discussion 
throughout.
Despite these shared priorities, there were significant differ-
ences between groups throughout. Although research into the 
role of rapid diagnostics and digital approaches to STI service 
delivery were repeatedly prioritised, views on the safety of the 
latter diverged markedly between and within participant groups.
As expected, P&P differed from C&S in their familiarity with 
research. C&S developed more specific research questions, more 
submissions overall, and were more likely to prioritise impact 
and effectiveness research and translation of research priorities 
into practice. P&P submitted more general priorities, reflected 
on personal experiences, submitted more disease- focused topics, 
and requested more innovation and developmental research. All 
but two of the surveys that were excluded from analysis because 
Figure 3 Top 10 STI research priorities for the North West by respondent group. Overlaps between the two lists are highlighted in grey. HPV, human 
papilloma virus; HSV, herpes simplex virus; PrEP, pre- exposure prophylaxis.
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the research questions were already answered belonged to P&P. 
This highlights the need for more public and patient education 
on the nature of research and on currently available research 
evidence. However, all participants regardless of background 
or familiarity with research were keen to be involved in setting 
the research agenda and proved passionate about improving STI 
care.
Strengths and limitations
Use of validated methodology,3 11 including stratified participa-
tory approaches, ensured P&P voices were adequately heard. 
Every effort was made during stage 2 to ensure that a fair, delib-
erative consensus was reached.
However, despite widespread dissemination of promotional 
material, for logistical reasons, the majority of participants were 
recruited through a single large urban sexual health clinic and 
the number of C&S is small; this increases risk of bias, limits 
generalisability and precludes identification of significant differ-
ences between age and gender groups. Challenges in scheduling 
meant that the majority of clinicians in the workshop worked for 
the same National Health Service trust. The fact that this is the 
largest STI service provider in the NW ensures representation 
of a key constituency, but means that more remote and smaller 
clinics are likely under- represented. Despite these limitations, 
our study size is comparable with published RPS studies in other 
disease areas.14–16
While telephone interviews are comparable with inperson 
interviews,17 there was no opportunity for interaction between 
P&P participants in stage 2 and subsequent generation of the 
rich discussion seen in the C&S workshops. Conversely, given 
the sensitive nature of STI, P&P may have appreciated the 
opportunity for private discussion.5 18 19
Despite our efforts, minority groups were under- represented 
in stage 2, which further limits the generalisability of the find-
ings. This lack of representation is not uncommon and has been 
noted as a barrier to PPI in many areas of research.5 20 Finally, 
limited understanding of the nature of research and the current 
state of STI knowledge meant that a large number of P&P 
responses were ineligible.
Comparison with other studies
Reports of STI RPS exercises are few. Our priorities are similar 
to those identified in Canada’s STI RPS exercise7—antimicro-
bial resistance, point- of- care tests for hard- to- reach groups, 
education in schools and targeted prevention activities—and are 
similar to those discussed in an international RPS exercise for 
multidrug- resistant gonorrhoea.8
A recent reflection on case studies on PPI in sexual health 
research6 advises that researchers should be flexible and adap-
tive and use creativity to ensure meaningful PPI. The authors 
suggest that PPI earlier in the research process, most notably in 
identifying research priorities, would be advantageous to sexual 
health research and echoes the purpose of this study. Within 
their case studies one- to- one discussions were initially preferred 
by lay participants and affirms our decision to use telephone 
interviews with P&P. We feel this may have boosted recruitment 
and ensured participants remained comfortable. McDonagh 
et al6 describe difficulties engaging potential end- users and 
recommend involving stakeholders as ‘professional proxies’ to 
gain insight into the needs of hard- to- reach, target populations, 
which are traditionally more difficult to access. This further 
supports our strategy of working synergistically with stake-
holders throughout this study.
Our research methods have been clearly documented to 
ensure transparency and enhance trustworthiness. To date this 
has been rare in priority- setting research16 and facilitates both 
replicability of the methods and development of strategies to 
address limitations in future research.
CONCLUSIONS
Until now, the P&P voice has typically been absent from STI RPS 
despite the public health importance of STI and the role of PPI 
for good research practice. This study addresses this gap by (1) 
identifying the top 10 STI priorities for STI research for C&S 
and for P&P, respectively; (2) demonstrating that large- scale 
PPI is feasible in STI agenda setting, although additional efforts 
are needed in improving public understanding of research and 
coverage of minority and vulnerable groups; and (3) by showing 
that while there is significant overlap between priorities, there 
are differences which highlight the need for inclusion of P&P 
perspectives in priority- setting. This must be supported by P&P 
education about the nature of research and the current state of 
STI knowledge if PPI is to be optimised.
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Key messages
 ► This is the first published UK STI research priority- setting 
exercise and therefore adds to the limited literature on public 
engagement in non- HIV sexual health services.
 ► STI education, targeted services for high- risk and vulnerable 
groups, STI treatment resistance, and counselling and 
emotional support were the highest research priorities.
 ► Key differences between patient concerns and those 
of clinicians and stakeholders highlighted the need to 
ensure patient and public involvement in STI research 
priority- setting.
 ► Despite sensitivities, patient and public involvement within 
STI research priority- setting is feasible and ensures that 
future research better meets the needs of service users.
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